SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-05-002524
Filing Date
2005-05-04
Accepted
2005-05-04 16:17:08
Documents
5
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 IDENIX PHARMACEUTICALS, INC. FORM 10-Q b54931ipe10vq.htm 10-Q 334737
2 EX-31.1 SECT. 302 CERTIFICATION OF THE C.E.O. b54931ipexv31w1.htm EX-31.1 7408
3 EX-31.2 SECT. 302 CERTIFICATION OF THE C.F.O. b54931ipexv31w2.htm EX-31.2 7677
4 EX-32.1 SECT. 906 CERTIFICATION OF THE C.E.O. b54931ipexv32w1.htm EX-32.1 3718
5 EX-32.2 SECT. 906 CERTIFICATION OF THE C.F.O. b54931ipexv32w2.htm EX-32.2 3438
  Complete submission text file 0000950135-05-002524.txt   358431
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET . CAMBRIDGE MA 02139 (617) 250-3100
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605
Type: 10-Q | Act: 34 | File No.: 000-49839 | Film No.: 05799380
SIC: 2834 Pharmaceutical Preparations